Home
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies

Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

NCT05082519

Conditions: B-cell Acute Lymphoblastic Leukemia, Body Weight, Burkitt Lymphoma, +29 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Orange County Orange, California, United States

UCSF School of Medicine San Francisco, California, United States

Colorado Children's Hospital Denver, Colorado, United States

View all 20 locations

View Trial Details

Recruiting

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

NCT05648019

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR, +28 more
Locations: Singapore General Hospital Singapore

KK Women's and Children's Hospital Singapore

View Trial Details

Recruiting

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

NCT05682131

Conditions: Arsenic Trioxide, Childhood ALL, Hematologic Diseases, +10 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

NCT05043571

Conditions: CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +16 more
Locations: Allen Yeoh Eng Juh Singapore

View Trial Details

Recruiting

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

NCT05038696

Conditions: CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +14 more
Locations: Allen Yeoh Eng Juh Singapore

View Trial Details

Recruiting

Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)

NCT04675918

Conditions: Cardiac Arrest, Cardiovascular Diseases, Heart Arrest, +14 more
Locations: Gregorio Marañon Hospital Madrid, Spain

View Trial Details

Recruiting

A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

NCT04227015

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

NCT04603872

Conditions: Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphocytic Leukaemia Refractory, Blood Protein Disorders, +28 more
Locations: The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

NCT04532203

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

NCT04532281

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions